These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. BACE: Therapeutic target and potential biomarker for Alzheimer's disease. Evin G, Barakat A, Masters CL. Int J Biochem Cell Biol; 2010 Dec 07; 42(12):1923-6. PubMed ID: 20817005 [Abstract] [Full Text] [Related]
11. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity. Fu H, Li W, Luo J, Lee NT, Li M, Tsim KW, Pang Y, Youdim MB, Han Y. Biochem Biophys Res Commun; 2008 Feb 15; 366(3):631-6. PubMed ID: 18039469 [Abstract] [Full Text] [Related]
12. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM. Acta Neuropathol; 2006 Aug 15; 112(2):163-74. PubMed ID: 16865398 [Abstract] [Full Text] [Related]
19. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Santosa C, Rasche S, Barakat A, Bellingham SA, Ho M, Tan J, Hill AF, Masters CL, McLean C, Evin G. Neurobiol Dis; 2011 Jul 15; 43(1):176-83. PubMed ID: 21440067 [Abstract] [Full Text] [Related]